Ghent University Academic Bibliography

Advanced

Combined effect of polymorphisms in Rad51 and XRCC3 on breast cancer risk and chromosomal radiosensitivity

Anne Vral UGent, Petra Willems UGent, Kathleen Claes UGent, Bruce Poppe UGent, Ans Baeyens, Gianpaolo Perletti and Hubert Thierens UGent (2011) MOLECULAR MEDICINE REPORTS. 4(5). p.901-912
abstract
Enhanced in vitro chromosomal radiosensitivity (CRS) has been proposed as a marker for low-penetrance gene mutations predisposing to breast cancer (BC). Since the double strand break (DSB) is the most detrimental form of DNA damage induced by ionizing radiation, it is possible that mutations in genes encoding proteins involved in DSB repair affect breast cancer risk. The purpose of the present study was to examine whether five single nucleotide polymorphisms (SNPs) in Rad51 and Xrcc3 (rs1801320, rs1801321, rs1799796, rs861539 and rs1799794) exhibited an association with breast cancer susceptibility in a Belgian population of BC patients with a known or putative genetic predisposition. We also ascertained whether a relationship exists between the occurrence of the 'variant' alleles of these variations and in vitro CRS. Blood samples were obtained from BC patients and from healthy female individuals. Variations in the 5' UTR of Rad51 and Xrcc3 were genotyped, and statistical analysis was performed. The results showed that low-penetrant variations in Rad51 and Xrcc3, two proteins belonging to the homologous recombination DSB repair pathway, may modify BC risk in patients already carrying a pathological mutation in the highly penetrant BC genes BRCA1 and BRCA2. Combined risk genotype analysis revealed that Rad51 SNPs enhance BC risk in BRCA2 patients, whereas Xrcc3 SNPs significantly enhance BC risk in carriers of BRCA1 mutations and in patients with hereditary BC. When four putative risk genotypes of Rad51 and Xrcc3 were combined, positive significant odds ratios were obtained in the entire patient population and in patients with a hereditary history of disease. Although obtained from a limited number of patients, our data are supportive of a polygenic model whereby combinations of weak variations are responsible for an enhanced BC risk by acting jointly with high-penetrant mutations in BRCA1 or BRCA2.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
BRCA1 CARRIERS, OVARIAN-CANCER, KU70/80 KNOCKDOWN, 5'-UNTRANSLATED REGION, 135G-GREATER-THAN-C POLYMORPHISM, MUTATION CARRIERS, HOMOLOGOUS RECOMBINATION, DNA-REPAIR GENES, SINGLE-NUCLEOTIDE POLYMORPHISMS, DNA repair, radiosensitivity, SUSCEPTIBILITY, Rad51, XRCC3, breast cancer, genetic polymorphisms
journal title
MOLECULAR MEDICINE REPORTS
Mol. Med. Rep.
volume
4
issue
5
pages
901 - 912
Web of Science type
Article
Web of Science id
000293435300020
JCR category
MEDICINE, RESEARCH & EXPERIMENTAL
JCR impact factor
0.418 (2011)
JCR rank
98/109 (2011)
JCR quartile
4 (2011)
ISSN
1791-2997
DOI
10.3892/mmr.2011.523
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1900602
handle
http://hdl.handle.net/1854/LU-1900602
date created
2011-09-13 15:36:54
date last changed
2011-12-06 11:54:19
@article{1900602,
  abstract     = {Enhanced in vitro chromosomal radiosensitivity (CRS) has been proposed as a marker for low-penetrance gene mutations predisposing to breast cancer (BC). Since the double strand break (DSB) is the most detrimental form of DNA damage induced by ionizing radiation, it is possible that mutations in genes encoding proteins involved in DSB repair affect breast cancer risk. The purpose of the present study was to examine whether five single nucleotide polymorphisms (SNPs) in Rad51 and Xrcc3 (rs1801320, rs1801321, rs1799796, rs861539 and rs1799794) exhibited an association with breast cancer susceptibility in a Belgian population of BC patients with a known or putative genetic predisposition. We also ascertained whether a relationship exists between the occurrence of the 'variant' alleles of these variations and in vitro CRS. Blood samples were obtained from BC patients and from healthy female individuals. Variations in the 5' UTR of Rad51 and Xrcc3 were genotyped, and statistical analysis was performed. The results showed that low-penetrant variations in Rad51 and Xrcc3, two proteins belonging to the homologous recombination DSB repair pathway, may modify BC risk in patients already carrying a pathological mutation in the highly penetrant BC genes BRCA1 and BRCA2. Combined risk genotype analysis revealed that Rad51 SNPs enhance BC risk in BRCA2 patients, whereas Xrcc3 SNPs significantly enhance BC risk in carriers of BRCA1 mutations and in patients with hereditary BC. When four putative risk genotypes of Rad51 and Xrcc3 were combined, positive significant odds ratios were obtained in the entire patient population and in patients with a hereditary history of disease. Although obtained from a limited number of patients, our data are supportive of a polygenic model whereby combinations of weak variations are responsible for an enhanced BC risk by acting jointly with high-penetrant mutations in BRCA1 or BRCA2.},
  author       = {Vral, Anne and Willems, Petra and Claes, Kathleen and Poppe, Bruce and Baeyens, Ans and Perletti, Gianpaolo and Thierens, Hubert},
  issn         = {1791-2997},
  journal      = {MOLECULAR MEDICINE REPORTS},
  keyword      = {BRCA1 CARRIERS,OVARIAN-CANCER,KU70/80 KNOCKDOWN,5'-UNTRANSLATED REGION,135G-GREATER-THAN-C POLYMORPHISM,MUTATION CARRIERS,HOMOLOGOUS RECOMBINATION,DNA-REPAIR GENES,SINGLE-NUCLEOTIDE POLYMORPHISMS,DNA repair,radiosensitivity,SUSCEPTIBILITY,Rad51,XRCC3,breast cancer,genetic polymorphisms},
  language     = {eng},
  number       = {5},
  pages        = {901--912},
  title        = {Combined effect of polymorphisms in Rad51 and XRCC3 on breast cancer risk and chromosomal radiosensitivity},
  url          = {http://dx.doi.org/10.3892/mmr.2011.523},
  volume       = {4},
  year         = {2011},
}

Chicago
Vral, Anne, Petra Willems, Kathleen Claes, Bruce Poppe, Ans Baeyens, Gianpaolo Perletti, and Hubert Thierens. 2011. “Combined Effect of Polymorphisms in Rad51 and XRCC3 on Breast Cancer Risk and Chromosomal Radiosensitivity.” Molecular Medicine Reports 4 (5): 901–912.
APA
Vral, A., Willems, P., Claes, K., Poppe, B., Baeyens, A., Perletti, G., & Thierens, H. (2011). Combined effect of polymorphisms in Rad51 and XRCC3 on breast cancer risk and chromosomal radiosensitivity. MOLECULAR MEDICINE REPORTS, 4(5), 901–912.
Vancouver
1.
Vral A, Willems P, Claes K, Poppe B, Baeyens A, Perletti G, et al. Combined effect of polymorphisms in Rad51 and XRCC3 on breast cancer risk and chromosomal radiosensitivity. MOLECULAR MEDICINE REPORTS. 2011;4(5):901–12.
MLA
Vral, Anne, Petra Willems, Kathleen Claes, et al. “Combined Effect of Polymorphisms in Rad51 and XRCC3 on Breast Cancer Risk and Chromosomal Radiosensitivity.” MOLECULAR MEDICINE REPORTS 4.5 (2011): 901–912. Print.